Preview Mode Links will not work in preview mode

AI For Pharma Growth

Oct 24, 2023

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Max Dordevic, Co-Founder & CEO at NeuroX1.

 

NeuroX1 is a company that utilises AI to identify and treat neurological diseases that affect millions of people every year. Max discusses how NeuroX1 brings their novel approach to the industry by working...


Oct 17, 2023

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Richard Graves, Chief Commercial Officer & Co-founder at Sorcero, to discuss how AI can be used to generate strategic literature reviews accurately and reduce costs for medical affairs teams.

 

Richard discusses his background in data science...


Oct 10, 2023

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Maddie Bell co-founder & CEO, Scheduler.AI.

 

Scheduler.AI's AI-powered virtual assistant helps schedule meetings effortlessly. Maddie discusses the background of starting Scheduling.AI, how long it took to develop the first version, challenges faced...


Oct 3, 2023

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Adam Kingl to discuss the future of leadership and innovation in pharma. While new technologies are creating medical breakthroughs, they also threaten major revenue decreases for pharma companies. Adam shares how assessing assumptions...